Quantcast

Latest BRCA1 Stories

2014-10-21 23:00:39

HealthForumOnline (HFO) has recently updated The Psychosocial Needs of Women Undergoing Genetic Counseling and Testing in the Breast Cancer Context, an online continuing education (CE) course for mental health professionals, to reflect advances in the field of genetics and clinical implications. HFO offers over 95 nationally-approved online CE courses for psychologists, social workers, counselors, marital family therapists and other allied health care providers that are fast, convenient...

Angelina Jolie Effect
2014-09-19 08:30:21

Chuck Bednar for redOrbit.com - Your Universe Online Angelina Jolie’s decision to have a double mastectomy after being told she would likely develop breast cancer had a tremendous impact on testing for the disease in the UK, the authors of a new Breast Cancer Journal study reported on Friday. According to BBC News online health editor Helen Briggs, referrals to breast cancer clinics more than doubled after Jolie announced last May that she had undergone the surgery after doctors...

2014-09-08 08:31:52

Kazutoshi Mori and Peter Walter for discoveries concerning the unfolded protein response--an intracellular quality-control system that detects harmful misfolded proteins in the endoplasmic reticulum and signals the nucleus to carry out corrective measures. NEW YORK, Sept. 8, 2014 /PRNewswire/ -- The Albert and Mary Lasker Foundation today announced the winners of the 2014 Lasker Awards: Kazutoshi Mori and Peter Walter for basic medical research; Alim Louis Benabid and Mahlon R....

2014-08-19 16:29:12

GILBERT, Ariz., Aug. 19, 2014 /PRNewswire/ -- A cutting-edge research study at Banner MD Anderson Cancer Center is testing the safety and effectiveness of a new investigational drug that, when combined with chemotherapy, may make a major difference in treating breast cancer in patients who carry harmful mutations on either the BRCA1 or BRCA2 genes. The Brocade Study will enroll patients with hereditary breast cancer that is metastatic, meaning it has spread to other parts of the...

Gene Increases Risk Of Developing breast Cancer To One In Three By Age 70
2014-08-08 03:08:44

University of Cambridge Breast cancer risks for one of potentially the most important genes associated with breast cancer after the BRCA1/2 genes are today reported in the New England Journal of Medicine. Women with mutations in the PALB2 gene have on average a one in three chance of developing breast cancer by the age of seventy. In a study run through the international PALB2 Interest Group a team of researchers from 17 centers in eight countries led by the University of Cambridge...

2014-06-26 08:27:43

- Trial will measure investigational compound's efficacy and safety in patients with HER2-negative breast cancer, associated with BRCA 1, BRCA 2 mutations NORTH CHICAGO, Ill., June 26, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the initiation of a Phase III clinical trial evaluating the safety and efficacy of its investigational compound, veliparib (ABT-888), when added to carboplatin and paclitaxel, two chemotherapeutic medicines, in patients with advanced breast...

2014-06-25 23:14:27

AllMed webinar provides in-depth review of the latest in standard of care for the genetic testing of breast and ovarian cancer. Portland, Oregon (PRWEB) June 25, 2014 Advances in genetic testing technology have improved detection rates for BRCA1 and BRCA2 mutations in individuals who are at high risk for breast and ovarian cancer, but some mutations are missed with standard genetic testing. During a recent AllMed webinar, Dr. Della Howell, board-certified hematologist-oncologist,...

breast cancer double mastectomy
2014-05-22 11:34:51

Brett Smith for redOrbit.com - Your Universe Online One year ago last week, Angelina Jolie announced in a New York Times op-ed that she had undergone a preventative double mastectomy – but now a new study indicates that surgically removing both breasts may be unnecessary for women who are diagnosed with cancer in a single breast. Published in the journal JAMA Surgery, the new study found that approximately 70 percent of women that have both breasts removed after having a breast cancer...

2014-04-04 12:23:54

These genes could explain why some women with high-risk mutations suffer from cancer while others do not Today we know that women carrying BCRA1 and BCRA2 gene mutations have a 43% to 88% risk of developing from breast cancer before the age of 70. Taking critical decisions such as opting for preventive surgery when the risk bracket is so wide is not easy. Spanish National Cancer Research Centre (CNIO) researchers are conducting a study that will contribute towards giving every woman far...

2014-03-26 23:25:49

Fulgent Diagnostics announces a clinical BRCA1/BRCA2 full gene sequencing test for $500. Temple City, California (PRWEB) March 26, 2014 In addition to the BRCA1/BRCA2 full gene sequencing test, Fulgent Diagnostics has also added a gene rearrangement test for an additional cost of $400. Fulgent Diagnostic's BRCA1/BRCA2 full gene sequencing test with rearrangement provides valuable information that can lead to potential treatment options that could mitigate certain risks. These options...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.